Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study

Jason Weatherald, Marie-Camille Chaumais, Laurent Savale, Xavier Jaïs, Andrei Seferian, Matthieu Canuet, Hélène Bouvaist, Pascal Magro, Anne Bergeron, Christophe Guignabert, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani

Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017
Journal Issue: July
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jason Weatherald, Marie-Camille Chaumais, Laurent Savale, Xavier Jaïs, Andrei Seferian, Matthieu Canuet, Hélène Bouvaist, Pascal Magro, Anne Bergeron, Christophe Guignabert, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015

Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008


Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010

REVEAL: a contemporary US pulmonary arterial hypertension registry
Source: Eur Respir Rev 2012; 21: 8-18
Year: 2012


Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort
Source: Eur Respir J, 49 (5) 1602275; 10.1183/13993003.02275-2016
Year: 2017



Prevalence of pulmonary arterial hypertension in idiopathic pulmonary fibrosis: a multicenter study
Source: Eur Respir J 2007; 30: Suppl. 51, 119s
Year: 2007

Determinants of self-efficacy in patients with pulmonary arterial hypertension: A pilot study
Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy
Year: 2016

Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010


French pulmonary arterial hypertension registry in children: 2-year follow-up data
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012

The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Adherence to guidelines of anticoagulant prescription in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an observational study
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019



Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: A monocentric study
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018
Year: 2018



Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir J, 50 (4) 1700465; 10.1183/13993003.00465-2017
Year: 2017